Is Sweetgreen Stock Worth Holding For the Next Five Years?
Sweetgreen (NYSE:SG) is an up-and-coming quick service restaurant chain focused…
Sell
20
STOK Quote, Financials, Valuation and Earnings
Last price:
$5.93
Seasonality move
:
-2.4%
Day range:
$5.66 - $6.20
52-week range:
$5.66 - $17.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.75x
P/B ratio:
1.40x
Volume:
1.1M
Avg. volume:
861.5K
1-year change:
-51.19%
Market cap:
$321.2M
Revenue:
$36.6M
EPS (TTM):
-$1.68
Earnings Data
Next earnings date for STOK
May 06
2025
Most recent earnings per share
-$0.18
Beat by $0.35
(Mar 18/2025)
Consensus Estimate
-$0.53
(Mar 18/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
STOK Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $31.7M | -- | -- | -$0.03 | -- |
| 05/06/2025 | Q1 | $27.4M | -- | -- | -$0.12 | -- |
| 03/18/2025 | Q4 | $4.3M | $22.6M | -$0.18 | -$0.53 | $0.35 |
| 11/05/2024 | Q3 | $3.6M | $4.9M | -$0.47 | -$0.54 | $0.07 |
| 08/07/2024 | Q2 | $3.3M | $4.8M | -$0.46 | -$0.56 | $0.10 |
| 05/06/2024 | Q1 | $3.2M | $4.2M | -$0.57 | -$0.61 | $0.04 |
| 03/25/2024 | Q4 | $3.2M | $2.8M | -$0.60 | -$0.63 | $0.03 |
| 11/07/2023 | Q3 | -- | -- | -$0.55 | -$0.65 | $0.10 |
| 08/07/2023 | Q2 | -- | -- | -$0.69 | -$0.66 | -$0.03 |
| 05/04/2023 | Q1 | -- | -- | -$0.53 | -$0.72 | $0.19 |
| 03/10/2023 | Q4 | -- | -- | -$0.65 | -$0.71 | $0.06 |
| 11/14/2022 | Q3 | -- | -- | -$0.66 | -$0.68 | $0.02 |
| 08/08/2022 | Q2 | -- | -- | -$0.63 | -$0.69 | $0.06 |
| 05/10/2022 | Q1 | -- | -- | -$0.66 | $0.13 | -$0.79 |
| 03/10/2022 | Q4 | -- | -- | -$0.66 | -$0.61 | -$0.05 |
| 11/08/2021 | Q3 | -- | -- | -$0.61 | -$0.55 | -$0.06 |
| 08/10/2021 | Q2 | -- | -- | -$0.60 | -$0.46 | -$0.14 |
| 05/10/2021 | Q1 | -- | -- | -$0.46 | -$0.44 | -$0.02 |
| 03/09/2021 | Q4 | -- | -- | -$0.42 | -$0.42 | $0.00 |
| 11/12/2020 | Q3 | -- | -- | -$0.41 | -$0.43 | $0.02 |
| 08/10/2020 | Q2 | -- | -- | -$0.39 | -$0.36 | -$0.03 |
| 05/15/2020 | Q1 | -- | -- | -$0.34 | -$0.37 | $0.03 |
| 03/23/2020 | Q4 | -- | -- | -$0.31 | -$0.30 | -$0.01 |
| 11/12/2019 | Q3 | -- | -- | -$0.26 | -$0.28 | $0.02 |
| 08/14/2019 | Q2 | -- | -- | -$1.54 | -$1.63 | $0.09 |
Stoke Therapeutics Earnings Questions
-
How Much did Stoke Therapeutics Generate in Revenue Last Quarter?
Stoke Therapeutics reported $22.6M worth of top line sales in its most recent quarter.
-
Did Stoke Therapeutics Beat Earnings Last Quarter?
Stoke Therapeutics announced earnings per share of -$0.18 which represents a beat of analyst forecast a -$0.53 per share.
-
Is Stoke Therapeutics Profitable?
Stoke Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Stoke Therapeutics EPS Next Year?
Stoke Therapeutics's earnings are forecast to decrease from -$1.65 per share to -$2.02 per share next year representing a decrease of -16.63%.
-
When is Stoke Therapeutics's Earnings Date?
Stoke Therapeutics's next earnings date is May 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Do I Need to Know About Alcoa Stock?
Alcoa (AA) is a global leader in aluminum production. Based…
Is ROOT Stock the Next Big Thing?
Root Holdings (NASDAQ:ROOT) is the parent company of Root Insurance,…
Stock Ideas
Sell
37
Is AAPL Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 31x
Sell
37
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
31
Is NVDA Stock a Buy?
Market Cap: $2.3T
P/E Ratio: 32x
Alerts
Sell
45
RGC alert for Apr 7
Regencell Bioscience Holdings [RGC] is down 9.19% over the past day.
Sell
25
GDXU alert for Apr 7
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 1.97% over the past day.
Buy
76
SOXS alert for Apr 7
Direxion Daily Semiconductor Bear 3X Shares [SOXS] is down 4.66% over the past day.
